The Glasgow Prognostic Score, an inflammation-based cancer-prognostic marker composed of serum elevation of CRP and decrease in albumin concentration, predicts patients with systemic inflammation as part of cancer cachexia and has been shown to have independent prognostic value (Laird et al., 2013). This evidence concerns the gene CRP and cancer.